← Back
Data updated: Mar 29, 2026
RUBICON RESEARCH
CardiovascularNeurologyOphthalmology
Generics
RUBICON RESEARCH is a generic drug manufacturer focused on Cardiovascular, Neurology, Ophthalmology.
1996
Since
59
Drugs
-
Trials
931
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 42%
8 drugs
Neurology 32%
6 drugs
Ophthalmology 11%
2 drugs
Immunology 11%
2 drugs
Oncology 5%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Novartis big-pharma
Oncology, Cardiovascular, Immunology, Ophthalmology
AbbVie big-pharma
Immunology, Oncology, Neurology, Ophthalmology
Roche big-pharma
Oncology, Neurology, Ophthalmology, Immunology
Merck big-pharma
Oncology, Cardiovascular, Immunology
Baxter specialty
Cardiovascular, Oncology, Ophthalmology
Active (38)
DESVENLAFAXINE SUCCINATE ARIPIPRAZOLE IVERMECTIN RABEPRAZOLE SODIUM CEVIMELINE HYDROCHLORIDE TRANEXAMIC ACID DORZOLAMIDE HYDROCHLORIDE DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OXCARBAZEPINE CARVEDILOL PANTOPRAZOLE SODIUM LAMOTRIGINE FLUTICASONE PROPIONATE CIPROFLOXACIN HYDROCHLORIDE METOLAZONE TOPIRAMATE MIDODRINE HYDROCHLORIDE DIHYDROERGOTAMINE MESYLATE LORATADINE TRAMADOL HYDROCHLORIDE BUSPIRONE HYDROCHLORIDE BISOPROLOL FUMARATE AMIODARONE HYDROCHLORIDE DICLOFENAC POTASSIUM ACYCLOVIR CLONAZEPAM ESTRADIOL GUANFACINE HYDROCHLORIDE DICLOFENAC SODIUM BUMETANIDE GLIPIZIDE METOPROLOL TARTRATE LOPERAMIDE HYDROCHLORIDE BACLOFEN TRIAMTERENE AND HYDROCHLOROTHIAZIDE AMANTADINE HYDROCHLORIDE NITROGLYCERIN ACETAZOLAMIDE
Discontinued (20)
GABAPENTIN PREGABALIN IPRATROPIUM BROMIDE AMITRIPTYLINE HYDROCHLORIDE BUPRENORPHINE HYDROCHLORIDE POTASSIUM CHLORIDE HALOPERIDOL TIZANIDINE HYDROCHLORIDE LOPRESSOR LIDOCAINE HYDROCHLORIDE LABETALOL HYDROCHLORIDE PRIMIDONE DICYCLOMINE HYDROCHLORIDE CARBIDOPA AND LEVODOPA CLONIDINE HYDROCHLORIDE CYCLOBENZAPRINE HYDROCHLORIDE LEVOFLOXACIN OXYBUTYNIN CHLORIDE NORTRIPTYLINE HYDROCHLORIDE LITHIUM CITRATE
Company Info
- First Approval
- 1996-03-14
- Latest
- 2026-01-02
- Applications
- 73